common.study.topics.clinical

Cell-Free DNA in Hereditary and High-Risk Malignancies

common.study.values.description

Cell-free DNA in Hereditary And High-Risk Malignancies

The goal of this study is to develop an effective, sensitive blood test that can detect early tumours in patients with known or suspected hereditary cancer syndromes (HCS). If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier cancer detection. The study will also use questionnaires and interviews to understand how patients feel about incorporating these tests into routine medical care, and the perceptions of the medical value of test results.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Recruiting patients only common.study.methods.is-healthy-yes

Genetic - Next generation sequencing (NGS)

NGS

participant.views.study.view.additional

participant.views.study.view.scientific-title

Early Detection of Cancer in High-risk Patients Through Cell-free DNA

common.study.values.clinical-trial-id

NCT04261972

participant.views.study.view.id

epYNra